HealthAratus Intelligence
Edwards Lifesciences
Edwards Lifesciences Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Do published findings about Edwards Lifesciences match what happens in practice?
Independent evidence is still being mapped for this technology.
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
• Edwards Lifesciences specializes in innovative heart valve therapies and hemodynamic monitoring solutions. • Pioneered transcatheter heart valve replacement (TAVR) with the SAPIEN series, enabling minimally invasive treatment for aortic stenosis. • Developed the EVOQUE tricuspid valve replacement system, the first…
Vendor & external product information, not independently verified by HealthAratus
Deployed in hospital settings, US, EU, Asia, Latin America
Regulatory: FDA approvals for SAPIEN series, EVOQUE system, MITRIS RESILIA valve, and Duravess patches, CE marks for European market
Transcatheter heart valve therapies, Tricuspid valve replacement systems, Mitral valve replacement solutions
Treatment of severe aortic stenosis via TAVR, Management of tricuspid regurgitation with transcatheter valve replacement, Mitral valve replacement using tissue valves
Cardiologists, Cardiac surgeons, Heart failure specialists
Connected intelligence
Category intelligence